Approx. 150 hospitals will be involved in SPIRIT 3. 1 000 patients will be recruited into the study over a period of 4 years. We anticipate 3-monthly deliveries of medication to all patients and patients will be on study meds for up to 10 years. Therefore there will be an estimated (1 000 x 4 x 10) = 40 000 deliveries over the lifetime of the project. During the period of the contract we may wish to offer a home phlebotomy service for trial patients.
Ref: T/11/286,
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Supplies Department Cheviot Court The Freeman Hospital High Heaton
For the attention of: Alan Brinton
NE7 7DN Newcastle upon Tyne
UNITED KINGDOM
Telephone: +44 1912137648
E-mail: alan.brinton@nuth.nhs.uk
Fax: +44 1912231051
Internet address(es):
General address of the contracting authority: http://www.newcastle-hospitals.org.uk
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
Contract value: SPIRIT 3 is a large phase 3 National Cancer Research Institute clinical trial which will begin recruitment in May/June 2013. The study is for patients with chronic myeloid leukaemia (CML) and will provide home delivery of imatinib and nilotinib (licensed, NICE approved) as well as ponatinib (not licensed as yet, provided free of charge from the trial).
Published: 30 Nov 2012, Receipt by: 28 Dec 2012
All suppliers that are registered with us receive email notifications of Public Sector tenders related to their area of business.
